Rubicon launches rapid whole genome amplification kit
This article was originally published in Clinica
Rubicon Genomics has launched its PicoPlex Single Cell Whole Genome Amplification (WGA) kit in the US and Europe. The kit is used to produce amplified DNA samples for markets including pre-implantation genetic diagnostics, and stem cell and cancer research. The Ann Arbor, Michigan firm claims the product is a more rapid, accurate and reproducible method for amplifying single genomes than current technologies. It enables reference labs to begin qPCR, microarray or sequencing analysis within three hours of collecting patients' cells, and can obtain the same amount of genomic information from one cell as was previously available from 10,000 cells, Rubicon added.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.